# Sabina A. Murphy

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/sabina-a-murphy/

## Facts

| Field | Value |
| --- | --- |
| Citations | 76,248 |
| Field | Acute Myocardial Infarction Research |
| h-index | 120 |
| i10-index | 384 |
| Last Known Institution | Brigham and Women's Hospital |
| OpenAlex ID | https://openalex.org/A5085897222 |
| ORCID iD | 0000-0002-8231-3611 |
| Works | 672 |

## Researcher papers

Showing 12 of 18.

- [Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes](https://scholariq.org/papers/prasugrel-versus-clopidogrel-in-patients-with-acute-coronary-syndromes/)
- [Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes](https://scholariq.org/papers/dapagliflozin-and-cardiovascular-outcomes-in-type-2-diabetes/)
- [Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease](https://scholariq.org/papers/evolocumab-and-clinical-outcomes-in-patients-with-cardiovascular-disease/)
- [Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction](https://scholariq.org/papers/long-term-use-of-ticagrelor-in-patients-with-prior-myocardial-infarction/)
- [Rivaroxaban in Patients with a Recent Acute Coronary Syndrome](https://scholariq.org/papers/rivaroxaban-in-patients-with-a-recent-acute-coronary-syndrome/)
- [TIMI Risk Score for ST-Elevation Myocardial Infarction: A Convenient, Bedside, Clinical Score for Risk Assessment at Presentation](https://scholariq.org/papers/timi-risk-score-for-st-elevation-myocardial-infarction-a-convenient-bedside/)
- [Clopidogrel with or without Omeprazole in Coronary Artery Disease](https://scholariq.org/papers/clopidogrel-with-or-without-omeprazole-in-coronary-artery-disease/)
- [Myocardial infarction accelerates atherosclerosis](https://scholariq.org/papers/myocardial-infarction-accelerates-atherosclerosis/)
- [Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial](https://scholariq.org/papers/prasugrel-compared-with-clopidogrel-in-patients-undergoing-percutaneous-coronary/)
- [Vorapaxar in the Secondary Prevention of Atherothrombotic Events](https://scholariq.org/papers/vorapaxar-in-the-secondary-prevention-of-atherothrombotic-events/)
- [Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials](https://scholariq.org/papers/efficacy-and-safety-of-statin-therapy-in-older-people-a-meta-analysis-of/)
- [Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE–TIMI 58 randomised trial](https://scholariq.org/papers/effects-of-dapagliflozin-on-development-and-progression-of-kidney-disease-in/)

## Researcher topics

- [Acute Myocardial Infarction Research](https://scholariq.org/topics/acute-myocardial-infarction-research/)
- [Antiplatelet Therapy and Cardiovascular Diseases](https://scholariq.org/topics/antiplatelet-therapy-and-cardiovascular-diseases/)
- [Cardiac Imaging and Diagnostics](https://scholariq.org/topics/cardiac-imaging-and-diagnostics/)
- [Coronary Interventions and Diagnostics](https://scholariq.org/topics/coronary-interventions-and-diagnostics/)
- [Lipoproteins and Cardiovascular Health](https://scholariq.org/topics/lipoproteins-and-cardiovascular-health/)

## Researcher university

- [Brigham and Women's Hospital](https://scholariq.org/institutions/brigham-and-women-s-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.